The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system, a form of mechanical ...

Penumbra, Inc. (NYSE: PEN) announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that ...

The first of its kind RCT in acute intermediate-high-risk PE used a surrogate endpoint, but more data are on the horizon.

Angiodynamics, Inc. (($ANGO)) announced an update on their ongoing clinical study. Study Overview: AngioDynamics, Inc. is conducting a ...

Penumbra (PEN) announced the results of the STORM-PE randomized controlled trial – RCT -, which found that the use of mechanical thrombectomy, ...

Penumbra, Inc. announced that the results of the STORM-PE randomized controlled trial showed that mechanical thrombectomy using ...

A randomized trial shows greater safety and effectiveness of the large-bore mechanical thrombectomy procedure than the catheter-directed intervention.

Penumbra Inc.’s 'resoundingly positive' results from its STORM-PE trial could see current guidelines for anticoagulant use in pulmonary embolism swept away in favor of mechanical thrombectomy. A ...

The use of mechanical thrombectomy (MT) was associated with reduced major adverse events in the short term and improved quality of life in the long term for pulmonary embolism (PE) patients with ...

New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

June Hoffman's shortness of breath snuck up on her. It started in the morning, hardly noticeable as she got dressed for a routine visit to her rheumatologists office. But by the time she reached the ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- ...